Glycine vs B-12 carrier: which compounded GLP-1 formulation is right
Both compounded GLP-1 formulations PeptideRx prescribes use the same active ingredient. The B-12 (cyanocobalamin) variant is the default and the glycine plus B-6 variant is the alternate. The carrier choice affects tolerability, methylation pathway loading, and price. It does not affect the weight-loss mechanism. This article walks the carrier comparison and helps the patient decide which formulation fits their physiology.
5 min read · Updated May 6, 2026
Medically reviewed by Dr. Jonathan Snipes, MD (NPI 1821250077). Last reviewed May 6, 2026.
The short answer
The active ingredient (semaglutide or tirzepatide) is chemically identical in both formulations. The carrier is what differs: cyanocobalamin (B-12) plus stabilizers in the default variant; glycine plus vitamin B-6 plus stabilizers in the glycine variant. The B-12 variant is the right choice for the majority of patients and costs less. The glycine variant is reserved for patients with documented B-12 sensitivity, MTHFR methylation gene variants, or histamine reactions to cyanocobalamin.
Side-by-side comparison
| B-12 variant (default) | Glycine variant | |
|---|---|---|
| Active ingredient | Semaglutide or tirzepatide | Same (identical molecule) |
| Carrier | Cyanocobalamin (B-12) at 0.5 mg/mL | Glycine + Vitamin B-6 (pyridoxine) |
| Weight-loss mechanism | GLP-1 (or dual GLP-1 + GIP) receptor activation | Same (carrier is pharmacologically inert) |
| Energy support | Yes (B-12 cofactor) | Indirect (B-6 supports homocysteine) |
| Hepatic detox support | Limited | Yes (glycine supports glutathione) |
| Best for | Standard candidate | B-12 sensitive, MTHFR variant, histamine reactive |
| Sema starter price | $25 / 1.2 mg | $175 / 10 mg |
| Tirz starter price | $45 / 12 mg | $225 / 60 mg |
The active ingredient is the same
Compounded semaglutide is a single chemical entity in both formulations. Compounded tirzepatide is a single chemical entity in both formulations. The molecules bind the same GLP-1 receptor (and, for tirzepatide, the GIP receptor) at the same affinity in both carrier choices. Pharmacokinetics, pharmacodynamics, and weight-loss mechanism are identical.
What differs is what the active is dissolved in. The B-12 variant uses cyanocobalamin as a soluble carrier that doubles as an energy cofactor during caloric deficit. The glycine variant uses the amino acid glycine plus vitamin B-6 as the carrier. Both buffer systems are sterile-tested and both formulations ship pre-reconstituted from Optimal Balance Pharmacy.
Why B-12 is the default carrier
B-12 is the most commonly used carrier across compounding pharmacies for several reasons:
- Solubility. Cyanocobalamin is highly water soluble and stabilizes the active in solution well.
- Energy cofactor. B-12 supports red blood cell production and methylation pathways under load during rapid fat loss. Patients in a strong caloric deficit often run low on B-12 and the carrier addresses this directly.
- Cost. B-12 raw material is inexpensive and the compounding workflow is well-validated, which keeps the price of the formulation low.
- Track record. B-12 has decades of compounded- injection use in lipotropic and methylation contexts; safety at the included dose (0.5 mg/mL) is well-established.
When the glycine variant is the right call
A subset of patients react to cyanocobalamin or have downstream methylation issues that make B-12 a poor carrier. Common signals:
- Documented B-12 sensitivity. Rash, redness, or anxiety reaction within hours of a B-12 injection or B-12- containing supplement.
- MTHFR methylation gene variant. Patients homozygous for C677T or compound heterozygous for C677T/A1298C often have impaired methylation and react poorly to cyanocobalamin specifically. Methylcobalamin is sometimes tolerated; cyanocobalamin is not.
- Copper-zinc imbalance or histamine reactions. Cyanocobalamin can occasionally exacerbate histamine reactions in patients with mast-cell activation patterns.
- Provider preference for cleaner cofactor profile. Some providers prefer glycine plus B-6 for patients on complex stacks where adding B-12 to the mix would muddy interpretation.
Why the glycine variant costs more
Three reasons. First, the glycine plus B-6 carrier uses more expensive raw materials than cyanocobalamin. Second, the compounding workflow for the glycine formulation is slightly more complex and produces lower batch yields per kilogram of active. Third, demand for the glycine variant is lower (it is reserved for the B-12 sensitive subset), so the per-vial overhead is spread across fewer doses.
PeptideRx does not mark up the medication. The price gap between the B-12 starter ($25 for semaglutide, $45 for tirzepatide) and the glycine starter ($175 for semaglutide, $225 for tirzepatide) reflects Optimal Balance Pharmacy’s actual cost difference, not a markup decision.
Bottom line
Most patients should start on the B-12 variant. It costs less, the cofactor is genuinely useful during caloric deficit, and the weight-loss effect is identical. Patients with documented B-12 sensitivity, MTHFR methylation variants, or histamine reactions should ask their provider about the glycine variant. The active ingredient is the same; the carrier is the variable.
Continue reading